As of Oct 5, 2026 close
- Market cap
- $73.61M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.89$2.09
- Volume (live)
- -
- Avg. volume (3M)
- 113.10K
Telomir Pharmaceuticals (TELO) Stock Price & Financial Analysis
Telomir Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.12 - $1.17 |
|---|---|
| 52-Week High | $2.09 |
| 52-Week Low | $0.89 |
| Open | $1.16 |
| Volume (last close) | 124.79K |
| Average Volume (3M) | 113.10K |
| Market Cap | 73.61M |
|---|---|
| Shares Outstanding | 60.84M |
| Price to Book (P/B) | 14.62 |
| EV/EBITDA | -11.65 |
| 50-Day MA | $1.17 |
|---|---|
| 200-Day MA | $1.25 |
| 1-Year Change | −37.31% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Telomir Pharmaceuticals at a Glance
Telomir Pharmaceuticals (TELO) has a market capitalization of $73.61M.
It holds $5.17M in cash and securities against $0.00 of debt, a net cash position of $5.17M.
Telomir Pharmaceuticals does not currently pay a dividend.
The share price is down 37.3% over the past year. At $1.12 it sits within its 52-week range of $0.89 to $2.09, below its 200-day moving average of $1.25.
Frequently Asked Questions About Telomir Pharmaceuticals
What is the current stock price for TELO?
As of the Oct 7, 2026 close, TELO stock trades at $1.12. The 52-week range is $0.89–$2.09, with a day range of $1.12–$1.17.
What is the P/E ratio for TELO?
The P/E ratio (Price-to-Earnings) for TELO is shown in the Key Statistics section. This valuation metric helps compare Telomir Pharmaceuticals, Inc. to industry peers.
Does TELO pay dividends?
Telomir Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TELO?
Analyst ratings and recommendations for TELO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TELO?
Telomir Pharmaceuticals's market capitalization is $68.1M, classifying it as a micro-cap company. Telomir Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.